Dr. Seet on the Need for Long-Term Outcome Data Regarding Treatment Discontinuation in CML
August 28th 2019Christopher S. Seet, MD, PhD, hematologist and oncologist, UCLA Health, discusses the need for long-term outcome data pertaining to treatment discontinuation in chronic myeloid leukemia (CML).
Read More